Global Age Related Macular Degeneration (AMD) Market Size, Status, Research and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 104

Report ID: 2066

Age related macular degeneration (AMD) is a condition wherein the macula the small central area of the retina in the eye is deteriorated.
In 2018, the global Age Related Macular Degeneration (AMD) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Age Related Macular Degeneration (AMD) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Age Related Macular Degeneration (AMD) development in United States, Europe and China.

The key players covered in this study
Bayer
F. HoffmannLa Roche
Regeneron
Novartis
Valeant
Pfizer
...

Market segment by Type, the product can be split into
Wet AMD
Dry AMD

Market segment by Application, split into
Men
Woman

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Age Related Macular Degeneration (AMD) status, future forecast, growth opportunity, key market and key players.
To present the Age Related Macular Degeneration (AMD) development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Age Related Macular Degeneration (AMD) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Age Related Macular Degeneration (AMD) Market Size Growth Rate by Type (2014-2025)
1.4.2 Wet AMD
1.4.3 Dry AMD
1.5 Market by Application
1.5.1 Global Age Related Macular Degeneration (AMD) Market Share by Application (2014-2025)
1.5.2 Men
1.5.3 Woman
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Age Related Macular Degeneration (AMD) Market Size
2.2 Age Related Macular Degeneration (AMD) Growth Trends by Regions
2.2.1 Age Related Macular Degeneration (AMD) Market Size by Regions (2014-2025)
2.2.2 Age Related Macular Degeneration (AMD) Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Age Related Macular Degeneration (AMD) Market Size by Manufacturers
3.1.1 Global Age Related Macular Degeneration (AMD) Revenue by Manufacturers (2014-2019)
3.1.2 Global Age Related Macular Degeneration (AMD) Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Age Related Macular Degeneration (AMD) Market Concentration Ratio (CR5 and HHI)
3.2 Age Related Macular Degeneration (AMD) Key Players Head office and Area Served
3.3 Key Players Age Related Macular Degeneration (AMD) Product/Solution/Service
3.4 Date of Enter into Age Related Macular Degeneration (AMD) Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Age Related Macular Degeneration (AMD) Market Size by Type (2014-2019)
4.2 Global Age Related Macular Degeneration (AMD) Market Size by Application (2014-2019)

5 United States
5.1 United States Age Related Macular Degeneration (AMD) Market Size (2014-2019)
5.2 Age Related Macular Degeneration (AMD) Key Players in United States
5.3 United States Age Related Macular Degeneration (AMD) Market Size by Type
5.4 United States Age Related Macular Degeneration (AMD) Market Size by Application

6 Europe
6.1 Europe Age Related Macular Degeneration (AMD) Market Size (2014-2019)
6.2 Age Related Macular Degeneration (AMD) Key Players in Europe
6.3 Europe Age Related Macular Degeneration (AMD) Market Size by Type
6.4 Europe Age Related Macular Degeneration (AMD) Market Size by Application

7 China
7.1 China Age Related Macular Degeneration (AMD) Market Size (2014-2019)
7.2 Age Related Macular Degeneration (AMD) Key Players in China
7.3 China Age Related Macular Degeneration (AMD) Market Size by Type
7.4 China Age Related Macular Degeneration (AMD) Market Size by Application

8 Japan
8.1 Japan Age Related Macular Degeneration (AMD) Market Size (2014-2019)
8.2 Age Related Macular Degeneration (AMD) Key Players in Japan
8.3 Japan Age Related Macular Degeneration (AMD) Market Size by Type
8.4 Japan Age Related Macular Degeneration (AMD) Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Age Related Macular Degeneration (AMD) Market Size (2014-2019)
9.2 Age Related Macular Degeneration (AMD) Key Players in Southeast Asia
9.3 Southeast Asia Age Related Macular Degeneration (AMD) Market Size by Type
9.4 Southeast Asia Age Related Macular Degeneration (AMD) Market Size by Application

10 India
10.1 India Age Related Macular Degeneration (AMD) Market Size (2014-2019)
10.2 Age Related Macular Degeneration (AMD) Key Players in India
10.3 India Age Related Macular Degeneration (AMD) Market Size by Type
10.4 India Age Related Macular Degeneration (AMD) Market Size by Application

11 Central & South America
11.1 Central & South America Age Related Macular Degeneration (AMD) Market Size (2014-2019)
11.2 Age Related Macular Degeneration (AMD) Key Players in Central & South America
11.3 Central & South America Age Related Macular Degeneration (AMD) Market Size by Type
11.4 Central & South America Age Related Macular Degeneration (AMD) Market Size by Application

12 International Players Profiles
12.1 Bayer
12.1.1 Bayer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Age Related Macular Degeneration (AMD) Introduction
12.1.4 Bayer Revenue in Age Related Macular Degeneration (AMD) Business (2014-2019)
12.1.5 Bayer Recent Development
12.2 F. HoffmannLa Roche
12.2.1 F. HoffmannLa Roche Company Details
12.2.2 Company Description and Business Overview
12.2.3 Age Related Macular Degeneration (AMD) Introduction
12.2.4 F. HoffmannLa Roche Revenue in Age Related Macular Degeneration (AMD) Business (2014-2019)
12.2.5 F. HoffmannLa Roche Recent Development
12.3 Regeneron
12.3.1 Regeneron Company Details
12.3.2 Company Description and Business Overview
12.3.3 Age Related Macular Degeneration (AMD) Introduction
12.3.4 Regeneron Revenue in Age Related Macular Degeneration (AMD) Business (2014-2019)
12.3.5 Regeneron Recent Development
12.4 Novartis
12.4.1 Novartis Company Details
12.4.2 Company Description and Business Overview
12.4.3 Age Related Macular Degeneration (AMD) Introduction
12.4.4 Novartis Revenue in Age Related Macular Degeneration (AMD) Business (2014-2019)
12.4.5 Novartis Recent Development
12.5 Valeant
12.5.1 Valeant Company Details
12.5.2 Company Description and Business Overview
12.5.3 Age Related Macular Degeneration (AMD) Introduction
12.5.4 Valeant Revenue in Age Related Macular Degeneration (AMD) Business (2014-2019)
12.5.5 Valeant Recent Development
12.6 Pfizer
12.6.1 Pfizer Company Details
12.6.2 Company Description and Business Overview
12.6.3 Age Related Macular Degeneration (AMD) Introduction
12.6.4 Pfizer Revenue in Age Related Macular Degeneration (AMD) Business (2014-2019)
12.6.5 Pfizer Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details